Lung Cancer
New vaccine could replace chemotherapy in certain patients with non-small-cell lung cancer.
Learn more
Dr. Nuño Cristina
Spezialist für Radioonkologie
The Clinical Trials Unit at HC Cancer Center aims to provide cancer patients with access to cutting-edge therapies.
Clinical trials are essential in the search for safer and more effective medical treatments, they represent an open door to innovation and hope for patients.
Participation in a clinical trial does not entail additional costs for patients, and they can be carried out in both public and private hospitals.
Consulting your doctor is the first step to finding out if there is an opportunity to participate in a clinical trial that could benefit you.
A clinical trial is any clinical research that is conducted in humans to determine or confirm the safety and efficacy of a drug. At the same time, they offer patients the possibility of accessing innovative treatments that could not otherwise be used…
Trials are classified according to their phase of development into:
PHASE I: First administration of the drug being researched in humans to study its tolerability, toxicity and metabolism, with preliminary activity data. It can be performed in both healthy patients and patients with the particular type of disease at which the drugs are targeted.
PHASE II: Administration of the drug to be researched in those who have the disease at which it is targeted. It is performed on a limited number of subjects and the aim is to obtain information about the safety and efficacy of treatment.
PHASE III: These are carried out in a larger number of subjects to confirm the safety and efficacy of a drug. These are usually studies that compare a standard treatment with an innovative treatment. Once this phase is completed, if the results are positive, marketing authorisation can be requested from the relevant authorities.
PHASE IV:These are performed once the drug is marketed and their aim is to gather more information about its safety, long-term side effects and/or new indications.
Clinical trials are strictly controlled and have to be approved beforehand by a Drug Research Ethics Committee (CEIm for its Spanish acronym) as well as by the Spanish Agency for Medicines and Health Products (AEMPS for its Spanish acronym). Similarly, they can only be carried out in centres with experience and have very strict requirements.
As a result, the administration of the research drug, similarly to those already marketed, is not without risks, but these usually consist of mild side effects.
Participation in a clinical trial is voluntary, the participant must meet a series of requirements (inclusion and exclusion criteria) which will determine whether or not they can participate in the clinical trial.
Cada ensayo clínico tiene sus criterios de inclusión y exclusión específicos.
Each clinical trial has specific inclusion and exclusion criteria.
Participation in a clinical trial should not generate any additional cost for patients, they can be carried out in both public and private centres, which often work as a network.
Your doctor can provide you with information on any trials which might benefit you, at any point during your disease.
New vaccine could replace chemotherapy in certain patients with non-small-cell lung cancer.
Learn more
New immunotherapy combination in first-line treatment for patients with head and neck cancer.
Learn more
Phase III study comparing an innovative immunotherapy treatment with standard chemotherapy in advanced lung cancer.
Learn more
Dr. Nuño Cristina
Spezialist für Radioonkologie
Dr. Trigo, José Manuel
Direktor für Onkologie, Forschung und Innovation
Dr. Cortés-Funes, Hernán
Präsident HC Marbella
Facharzt für Medizinische Onkologie
Dr. Jiménez Rodríguez, Begoña
Facharzt für Medizinische Onkologie
Klinische Engagement bei Brust-und gynäkologischen Krebs
Dr. Villatoro Roldán, Rosa Mª
Facharzt für Medizinische Onkologie
Dr. Llácer Pérez, Casilda
Facharzt für Medizinische Onkologie
Klinische Engagement bei Verdauungstumoren und Darmkrebs
Dr. Sedano Ferreras, Paula
Spezialist für Radioonkologie
Dr. García Baltar, José Antonio
Especialista en Radiofísica Hospitalaria
Dr. Ponce Aix, Santiago
Facharzt in Medizinischer Onkologie
Klinische Widmung bei Lungenkrebs
Präzisionsmedizin
Krebs-Immuntherapie
Dr. Bennis, Mohamed Hassan
Facharzt in Onkologie
Klinische Widmung an Lymphome
Tel.: +34 952 908 628
+34 609 148 799
952908898 Onkologie
951829978 Bildgebende Diagnostik
951829947 Gynäkologie
952908897 Fertilitäts-Zentrum
951829947 Physiotherapie
